JAN 15, 2020 9:41 PM PST

Laser microchip picks up cancer markers in urine

WRITTEN BY: Tara Fernandez

A future where patients no longer need to endure expensive, painful and complicated cancer tests could soon become a reality. Researchers have developed a new diagnostic technology capable of detecting trace amounts of cancer biomarkers in urine samples. With further refinements, the label-free, chip-based device could completely revolutionize health monitoring practices as we know them. 

Biomarkers are molecules in the body such as proteins, DNA and hormones, whose levels are indicative of the presence of disease. Measuring and monitoring biomarker levels are vital in designing effective, personalized therapies for each patient.

 

 

Speaking on the immense potential of the platform, Professor in Applied Physics at the University of Twente in the Netherlands, Sonia M. Garcia-Blanco, said, "The new technology we developed paves the way to faster and ultra-sensitive detection of panels of biomarkers that will permit doctors to make timely decisions that improve personalized diagnosis and treatment of medical conditions including cancer."

Patients could say goodbye to having to take invasive tissue biopsies. Instead, providing routine urine samples would be enough for providing critical insights to physicians before, during and after cancer treatment.

On the optical microchip, laser light moving through the urine samples changes in frequency when it crosses paths with the cancer biomarker. The team validated the chip's application using the cancer biomarker, S100A4. This is a protein that normally regulates changes in cell shape as cells move or migrate. When S100A4 levels are elevated in body fluids, it acts as a prime candidate as an early biomarker for cancer, signaling the presence of metastatic tumors.

Among the challenges faced by Garcia-Blanco and the team was the urgent need for an improved diagnostic tool that is easily mass-produced, inexpensive, disposable and does not require extensive technical expertise to interpret results.

Impressively, their microchip was able to tick all the boxes and on top of that, was able to detect S100A4 with incredible sensitivity. The system was capable of picking up the biomarker from human samples at concentrations as low as 300 picomoles. For reference, that's the equivalent of positively detecting 200 millionths of a gram of salt in a liter of water.

The next steps for the group involve further simplifying the system, as well as expanding its capabilities, allowing it to spot even more known cancer biomarkers.

 

Sources: MedGadget, Optics Letters

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 29, 2020
Cannabis Sciences
Hemp 10 Years from Now
OCT 29, 2020
Hemp 10 Years from Now
The hemp industry has experienced major growth in recent years, largely due to legalization in many US states. Today, th ...
NOV 16, 2020
Clinical & Molecular DX
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
NOV 16, 2020
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
The demand for diagnostic technologies to track COVID-19 infections and control community spread of the disease has only ...
DEC 15, 2020
Clinical & Molecular DX
Who Should Get the COVID Vaccine First?
DEC 15, 2020
Who Should Get the COVID Vaccine First?
Drug developers’ frantic hunt for vaccines against SARS-CoV-2 has finally begun to bear fruit, with several vaccin ...
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
JAN 26, 2021
Cell & Molecular Biology
Diagnostic Tool Could ID 20% of Autism Cases
JAN 26, 2021
Diagnostic Tool Could ID 20% of Autism Cases
Scientists may have created a diagnostic test that can identify as many as one-fifth of potential autism spectrum disord ...
FEB 25, 2021
Clinical & Molecular DX
Pure Gold: Mini Device Makes 3D Skin Maps
FEB 25, 2021
Pure Gold: Mini Device Makes 3D Skin Maps
Beauty is skin deep and so are wounds. Closely monitoring wound healing progress has been a challenge for doctors, mainl ...
Loading Comments...